Page last updated: 2024-09-05

lenalidomide and Constitutional Liver Dysfunction

lenalidomide has been researched along with Constitutional Liver Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adam, Z; Adamová, Z; Boichuk, I; Dvořáková, K; Koukalová, R; Král, Z; Krejčí, M; Packová, B; Pour, L; Řehák, Z; Sandecká, V; Štork, M	1

Other Studies

1 other study(ies) available for lenalidomide and Constitutional Liver Dysfunction

Article	Year
Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2022,Summer, Volume: 35, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bortezomib; Dexamethasone; Gilbert Disease; Humans; Hyperbilirubinemia; Lenalidomide; Multiple Myeloma; Necrobiotic Xanthogranuloma; Positron Emission Tomography Computed Tomography	2022

Article

Year

Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2022,Summer, Volume: 35, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bortezomib; Dexamethasone; Gilbert Disease; Humans; Hyperbilirubinemia; Lenalidomide; Multiple Myeloma; Necrobiotic Xanthogranuloma; Positron Emission Tomography Computed Tomography

2022